Research
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d2151 (Published 21 April 2011) Cite this as: BMJ 2011;342:d2151
Related articles
- Editorial Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2519
- Paper Published: 13 January 1996; BMJ 312 doi:10.1136/bmj.312.7023.83
- Paper Published: 21 July 2001; BMJ 323 doi:10.1136/bmj.323.7305.131
- Research Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2890
- Fillers Published: 11 November 2000; BMJ 321 doi:10.1136/bmj.321.7270.1190
- Research Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2921
- Research Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2139
- News Published: 20 June 2011; BMJ 342 doi:10.1136/bmj.d3854
- News Published: 13 December 2011; BMJ 343 doi:10.1136/bmj.d8104
- News Published: 10 January 2012; BMJ 344 doi:10.1136/bmj.e244
- News Published: 08 January 2013; BMJ 346 doi:10.1136/bmj.f121
- Research Published: 12 September 2013; BMJ 347 doi:10.1136/bmj.f5298
- Research Published: 05 November 2013; BMJ 347 doi:10.1136/bmj.f6320
- Letter Published: 31 May 2011; BMJ 342 doi:10.1136/bmj.d3344
- Letter Published: 16 April 2013; BMJ 346 doi:10.1136/bmj.f2369
- Research Published: 26 May 2015; BMJ 350 doi:10.1136/bmj.h2135
- Research Published: 10 May 2016; BMJ 353 doi:10.1136/bmj.i2002
- Student Published: 27 May 2011; BMJ 342 doi:10.1136/sbmj.d3139
See more
- Medicalisation of female genital mutilation is a dangerous developmentBMJ February 07, 2023, 380 p302; DOI: https://doi.org/10.1136/bmj.p302
- UK should screen for tyrosinaemia in newborn babies, committee recommendsBMJ February 02, 2023, 380 p275; DOI: https://doi.org/10.1136/bmj.p275
- Ovarian cancer: Loyalty card data could help identify cases soonerBMJ January 30, 2023, 380 p227; DOI: https://doi.org/10.1136/bmj.p227
- Maternity care: Entonox is withdrawn from some hospitals because of risk to staff from high exposureBMJ January 27, 2023, 380 p212; DOI: https://doi.org/10.1136/bmj.p212
- Maternity care has deteriorated in past five years owing to staff availability, finds regulatorBMJ January 11, 2023, 380 p77; DOI: https://doi.org/10.1136/bmj.p77
Cited by...
- Womens health in The BMJ: a data science history
- Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study
- Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
- Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
- Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databases
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Venous Thromboembolic Disease
- Continuation rates of oral hormonal contraceptives in a cohort of first-time users: a population-based registry study, Sweden 2005-2010
- Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis
- Authors' reply to Costescu and Waddington
- Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases
- French doctors are told to restrict use of third and fourth generation oral contraceptives
- Risk of venous thromboembolism in oral contraceptive users varies according to progestin type
- Long-term tolerability of ethinylestradiol 20 {micro}g/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study
- Risk of venous thromboembolism with oral contraceptives
- Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study
- Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel
- DTB Select: 6 | July 2011
- Venous thromboembolism is egregiously underestimated
- Levonorgestrel-Containing Oral Contraceptives: Still Among the Safest of the Safe
- Two case-control studies: risk of venous thromboembolism with oral contraceptives
- The risk of deep venous thrombosis with oral contraceptives containing drospirenone